Literature DB >> 26447893

The Potential Prognostic Value of Connexin 43 Expression in Head and Neck Squamous Cell Carcinomas.

Kornél Dános1, Diána Brauswetter, Ede Birtalan, Anna Pató, Gabriella Bencsik, Tibor Krenács, István Peták, László Tamás.   

Abstract

Gap juctions are transmembrane communication channels known to be involved in the control of cell proliferation by mediating the exchange of ions and small molecules between cells. Gap junctions are composed of connexon hemichannels made up of 6 connexin proteins, which abnormal expression and functions have been linked to tumor progression and poorer prognosis. Here, we studied the prognostic impact of the most prevalent connexin isotype, connexin 43 (Cx43) in head and neck squamous cell carcinomas (HNSCC). Tissue microarrays made from tumor samples of 90 HNSCC patients were immunostained for Cx43 and cell cycle regulation-related biomarkers including p53, Ki67, p16, aurora A, geminin, and p21 proteins. Scoring and histopathologic evaluation were performed in digital slides. A 4-tier scoring distinguishing the percentage of positively stained tumor cells was used including score 1: <5%, score 2: 6% to 20%, score 3: 21% to 60%, and score 4: >60%. For statistics, Kaplan-Meier curves with log-rank tests, Cox-regression, and Pearson χ/Fisher exact tests were used.A significant positive correlation was found between Cx43 expression and disease-specific survival of patients (P=0.004). The rate of p21 protein-positive tumor cells also proved to be a significant positive prognostic marker (P=0.014). Cx43 levels also showed a significant positive correlation with p53 expression (P=0.036). However, there was no statistical association between Cx43 levels and the rest of the markers tested neither with T, N, or M stage.In conclusion, our data suggest that reduced Cx43 expression and low p21 protein levels may have a significant negative impact on HNSCC prognosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26447893     DOI: 10.1097/PAI.0000000000000212

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  10 in total

1.  Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway.

Authors:  Xiao-Lin Ai; Qiang Chi; Yu Qiu; Hong-Yang Li; Dong-Jie Li; Jia-Xu Wang; Zhi-Yong Wang
Journal:  Mol Cell Biochem       Date:  2017-01-10       Impact factor: 3.396

2.  Analysis of GJB2 mutations and the clinical manifestation in a large Hungarian cohort.

Authors:  Nóra Kecskeméti; Magdolna Szönyi; Anita Gáborján; Marianna Küstel; György Máté Milley; Anna Süveges; Anett Illés; Anna Kékesi; László Tamás; Mária Judit Molnár; Ágnes Szirmai; Anikó Gál
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-09       Impact factor: 2.503

Review 3.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

Review 4.  Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.

Authors:  Nagore Del-Río-Ibisate; Rocío Granda-Díaz; Juan P Rodrigo; Sofía T Menéndez; Juana M García-Pedrero
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 5.  Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.

Authors:  María Alejandra Gleisner; Mariela Navarrete; Francisca Hofmann; Flavio Salazar-Onfray; Andrés Tittarelli
Journal:  Front Immunol       Date:  2017-09-01       Impact factor: 7.561

Review 6.  Connexins in cancer: bridging the gap to the clinic.

Authors:  Trond Aasen; Edward Leithe; Sheila V Graham; Petra Kameritsch; María D Mayán; Marc Mesnil; Kristin Pogoda; Arantxa Tabernero
Journal:  Oncogene       Date:  2019-02-27       Impact factor: 9.867

7.  BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients.

Authors:  Yu Wu; Huijuan Wang; Jingtai Zhi; Linfei Hu; Xiukun Hou; Xianhui Ruan; Xiangqian Zheng; Hui Liu; Ming Gao
Journal:  Onco Targets Ther       Date:  2019-08-28       Impact factor: 4.147

8.  Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.

Authors:  Lilla Pethő; József Murányi; Kinga Pénzes; Bianka Gurbi; Diána Brauswetter; Gábor Halmos; Gabriella Csík; Gábor Mező
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

9.  The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies.

Authors:  Bianka Gurbi; Diána Brauswetter; Attila Varga; Pál Gyulavári; Kinga Pénzes; József Murányi; Veronika Zámbó; Ede Birtalan; Tibor Krenács; David Laurence Becker; Miklós Csala; István Vályi-Nagy; István Peták; Kornél Dános
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

Review 10.  Connexins and Glucose Metabolism in Cancer.

Authors:  Jennifer C Jones; Thomas M Bodenstine
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.